Literature DB >> 12032327

Immunoglobulin heavy chain constant regions regulate immunity and tolerance to idiotypes of antibody variable regions.

Solveig Klaebo Reitan1, Kristian Hannestad.   

Abstract

Particular syngeneic adjuvant-free monoclonal antibodies are immunogenic and elicit antibody responses against the variable region idiotypes (Ids). We here study how heavy-chain constant regions (C(H)) regulate immune responses to Ids of free, uncomplexed monoclonal antibodies. To this end, we selected two hybridomas, called Id(3) and Id(A.01), that produce immunogenic IgM(lambda)2 directed toward 2,4,6-trinitrophenyl, and subcloned rare IgG1, IgG3, IgE, or IgA class switch variants. The purified switch variants, which possessed the Ids of their IgM progenitors, were injected repeatedly without added adjuvant into BALB/c mice, and anti-Id IgG responses were determined. These repeated injections revealed that the immunogenicity of Ids was lost by switching to IgG1 and IgG3, restored when the Fc piece of IgG1 was removed, maintained by switching to IgE and monomeric IgA, and lost in polymeric IgA. Loss of immunogenicity was associated with acquisition of Id-specific tolerogenicity, as determined by immunization challenge with Id borne by IgM. An Id borne by IgG induced tolerance when injected at least 90 days before or 3-21 days after immunization with IgM Id was begun. Ids of IgG were also tolerogenic in mice deficient in Fc(gamma)RIIB or Fc(gamma)RI + III. The results suggest that Ids that have switched to IgG and pIgA negatively control immune responses to shared Ids, including the Ids of their IgM progenitors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032327      PMCID: PMC124293          DOI: 10.1073/pnas.052150899

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  B cells turn off virgin but not memory T cells.

Authors:  E J Fuchs; P Matzinger
Journal:  Science       Date:  1992-11-13       Impact factor: 47.728

Review 2.  Fc receptors.

Authors:  J V Ravetch; J P Kinet
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

3.  Fc gamma RII-B1 regulates the presentation of B cell receptor-bound antigens.

Authors:  S A Minskoff; K Matter; I Mellman
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

Review 4.  Divergent roles for Fc receptors and complement in vivo.

Authors:  J V Ravetch; R A Clynes
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

5.  Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4+ T cells.

Authors:  K A Pape; A Khoruts; A Mondino; M K Jenkins
Journal:  J Immunol       Date:  1997-07-15       Impact factor: 5.422

6.  Co-crosslinking Fc epsilon RII/CD23 and B cell surface immunoglobulin modulates B cell activation.

Authors:  K A Campbell; A Lees; F D Finkelman; D H Conrad
Journal:  Eur J Immunol       Date:  1992-08       Impact factor: 5.532

7.  A syngeneic idiotype is immunogenic when borne by IgM but tolerogenic when joined to IgG.

Authors:  S K Reitan; K Hannestad
Journal:  Eur J Immunol       Date:  1995-06       Impact factor: 5.532

8.  C3d of complement as a molecular adjuvant: bridging innate and acquired immunity.

Authors:  P W Dempsey; M E Allison; S Akkaraju; C C Goodnow; D T Fearon
Journal:  Science       Date:  1996-01-19       Impact factor: 47.728

9.  Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses.

Authors:  R Yuan; R Clynes; J Oh; J V Ravetch; M D Scharff
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

10.  Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens.

Authors:  E E Eynon; D C Parker
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  11 in total

1.  Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma.

Authors:  Stephen J Schuster; Sattva S Neelapu; Barry L Gause; John E Janik; Franco M Muggia; Jon P Gockerman; Jane N Winter; Christopher R Flowers; Daniel A Nikcevich; Eduardo M Sotomayor; Dean S McGaughey; Elaine S Jaffe; Elise A Chong; Craig W Reynolds; Donald A Berry; Carlos F Santos; Mihaela A Popa; Amy M McCord; Larry W Kwak
Journal:  J Clin Oncol       Date:  2011-05-31       Impact factor: 44.544

2.  Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes".

Authors:  Anne S De Groot; Leonard Moise; Julie A McMurry; Erik Wambre; Laurence Van Overtvelt; Philippe Moingeon; David W Scott; William Martin
Journal:  Blood       Date:  2008-07-25       Impact factor: 22.113

3.  Immunoglobulin isotype influences affinity and specificity.

Authors:  Arturo Casadevall; Alena Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

4.  Variable Region Identical IgA and IgE to Cryptococcus neoformans Capsular Polysaccharide Manifest Specificity Differences.

Authors:  Alena Janda; Ertan Eryilmaz; Antonio Nakouzi; Mary Ann Pohl; Anthony Bowen; Arturo Casadevall
Journal:  J Biol Chem       Date:  2015-03-16       Impact factor: 5.157

Review 5.  Successes, failures and new perspectives of idiotypic vaccination for B-cell non-Hodgkin lymphomas.

Authors:  Elena Muraro; Debora Martorelli; Riccardo Dolcetti
Journal:  Hum Vaccin Immunother       Date:  2013-02-13       Impact factor: 3.452

6.  Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins.

Authors:  Alejandro López-Requena; Oscar R Burrone; Michela Cesco-Gaspere
Journal:  Front Oncol       Date:  2012-11-09       Impact factor: 6.244

7.  Potential application of tregitopes as immunomodulating agents in multiple sclerosis.

Authors:  Wassim Elyaman; Samia J Khoury; David W Scott; Anne S De Groot
Journal:  Neurol Res Int       Date:  2011-09-15

8.  The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii merozoite surface protein 1-19 (MSP1(19)).

Authors:  Jaime R Adame-Gallegos; Jianguo Shi; Richard S McIntosh; Richard J Pleass
Journal:  Exp Parasitol       Date:  2012-02-10       Impact factor: 2.011

9.  Activation and tolerance in CD4(+) T cells reactive to an immunoglobulin variable region.

Authors:  Christopher M Snyder; Katja Aviszus; Ryan A Heiser; Daniel R Tonkin; Amanda M Guth; Lawrence J Wysocki
Journal:  J Exp Med       Date:  2004-06-28       Impact factor: 14.307

10.  P3 mAb: An Immunogenic Anti-NeuGcGM3 Antibody with Unusual Immunoregulatory Properties.

Authors:  Darel Martínez; Nely Rodríguez; Tania Griñán; Teresa Rondón; Ana María Vázquez; Rolando Pérez; Ana María Hernández
Journal:  Front Immunol       Date:  2012-04-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.